chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning a 51 yr old white male with no preexisting allergies, birth defects, or medical conditions reported. On 08Dec05, at 3:10 PM (also reported as 3:20PM), the pt was vaccinated IM in the right arm (also reported as left arm) with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). On 09Dec05, the pt complained of soreness of the right arm, but was not seen by the physician. The pt recovered on 12Dec05. A product quality complaint was not involved. In a follow up it was reported that on 09Dec05 the pt developed a shot area has fever and was red (also reported as shot area red and feverish) and was swollen down past elbow. It was reported that the pt was feeling bad and experienced an arm sore. At the time of this report, the pt had recovered from the events (date unk). No further information is available.
Information has been received from a physician concerning a female consumer who on an unspecified date was vaccinated with a dose of zoster vaccine live (Oka/Merck). Subsequently, 1 week after the vaccine was administered the patient developed redness, itching, and swelling at the injection site. Medical attention was sought, the patient called the physician. It was unspecified if lab studies were performed. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
Patient presented to my office 12/9/21 for routine office visit with reports that she had to have a D&C on 10/25/21 "baby boy" at 14 weeks pregnant. This was 20 days after her first COVID-19 Pfizer vaccine in otherwise healthy female who has healthy sons age 4 and 7,
States that she had Covid right before she got that vaccine; Extremely sick after first dose of vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient received BNT162b2 (BNT162B2), on 27Feb2021 as dose 1, single (Lot number: EN6203) at the age of 42 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: OFF LABEL USE (non-serious), outcome "unknown", described as "States that she had Covid right before she got that vaccine"; ILLNESS (non-serious), outcome "unknown", described as "Extremely sick after first dose of vaccine".  Additional information: Consumer stated that she did not know if she has the right person to speak with. Stated she has been to a couple of doctors and went to neurology. The neurology office gave her this number to call Pfizer. Consumer stated that she had her first dose of the vaccine 27Feb of last year.  Stated that she had Covid right before she got that vac-cine. Stated she understands that now they tell you to wait 90 days after Covid to get the vaccine, but at that time, they were just telling you to get the vaccine. Consumer stated that she felt extremely sick after that first vaccine, by the time she started to feel better; it was time for her second vaccine. Consumer stated that in Sep she started having a weird feeling in her left arm. Did any AE(s) require a visit to: Physician Office: Yes
Patient received 2nd dose of covid vaccine. After vaccine was administered she appeared anxious. After about a minute, patient appeared to have a short seizure for 10 seconds. Patient appeared pale afterwards. Patient stated she had a history of passing out after vaccines. Ambulance came and evaluated her. She was released to go home with parent.
This spontaneous report as received from a physician refers to a male patient of unknown age. On 19-DEC-2013 the patient was vaccinated with ZOSTAVAX, subcutaneous. No details regarding the dosing regimen were provided. It was unknown if the patient received any co-suspected or concomitant medications. On 09-JAN-2014, the patient experienced patient deceased. No further details were provided. The action taken with ZOSTAVAX was unknown and a causality assessment was not provided. Additional information has been requested.
Information has been received from a consumer concerning her 5 year old son who on 4/9/97 was vaccinated with 1 dose of varicella virus vaccine live (site unknown). On approximately 11/9/01, the pt developed chickenpox and was treated by a physician. The consumer noted, "I was under the impression that vaccines were given to prevent diseases, however, both my sons contracted the disease". Additional information has been requested.
High fever - up to 102 when I normally register 97.1 on our home thermometer Achy; chills; headache Slept a lot; no appetitive Blood sugars went crazy on the high side.  I am normally very well regulated in the morning ranging from 80 to 90 - has not been below 150 in the am the last couple of days.   Diarreha.
Pt was nervous about vaccine. Does not like needles. After the vaccine, during the 15 min waiting time, pt became very sweaty, could not hear and passed out for about 10 seconds. He did not fall, he was seated but was unaware what had happened to him. Emergency number was then called and by the time they came the pt was fine. His vitals were normal.
Full body muscle aches. Treated with rest and drinking extra fluids. Symptoms dissipated in 24 hours.
Initial unsolicited report received from nurse on 25-Apr-2018. This case involves four months old male patient who was vaccinated with 0.5 ml dose of QUADRACEL (batch number, expiry date was not reported) once, intramuscularly in left thigh on 20 Apr 2018. The patient's medical history and concomitant medication were not reported. On an unspecified date, following the vaccination, patient had hives, diarrhea, vomiting, fever and a red swollen warm area on the left thigh. On 21 Apr 2018, patient was taken to emergency room. Laboratory investigation and corrective treatment were not reported. Patient was not recovered from events. Follow up information was received from nurse on 22-May-2018. The batch number for the suspect vaccine QUADRACEL was updated as C5222AA. It was reported that patient had no pre-existing-diagnosed allergies, birth defects and medical conditions and also no illness at time of vaccination. Concomitant medications included patient was vaccinated with PNEUMOCOCCAL VACCINE 13V, HIB VACCINE CONJ (HAEMOPHILUS INFLUENZAE TYPE B VACCINE CONJUGATED) and ROTAVIRUS VACCINE (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. On an unknown date, patient was recovered/resolved from all the events. On an unknown date, patient was performed KUB (kidney-urinary-bludder) Radiography (result: not reported). Patient was received BACITRACIN/ NEOMYCIN/ POLYMYXIN B for as a corrective treatment for vaccination site inflammation on an unknown date. List of documents held by sender: none.
Flu like symptoms, muscle weakness,  aches and pains, severe dizziness for two weeks followed by consistent ringing in ears since.
Redness, swelling, enlarged lymph nodes, treated with antibiotics as a precaution, site is on right thigh.
Very sore arm at first; 12 hours later fever, chills, red rash and itching over the entire body, Benadryl administered 24 hours after shot received.
presented to the ED of increased cough she was dx with covid about a week ago in the ED she was hypoxic and admitted for treatment
Beginning 12 hours after vaccine experienced chills, aches, nausea and headache. Also experiencing pain and swelling at injection site.
I have experienced muscle pain, headache and tiredness after the injection, but I though it's usual symptoms after vaccination and didn't report it. Then I start experiencing chest pain  with  increased blood pressure on Day 8 after injection. These symptoms were continuing about 10 days. I started treatment with Hydralazine 50 mg daily, Atenolol 50 mg daily, Hydrochlorothiazide 25 mg daily, Ibuprofen 600 mg twice a day, Lisinopril 20 mg daily and continued  this treatment for10 days until my blood pressure start normalizing, chest pain, headache and muscle pain disappeared.
After first pill of Vivotif tiphoid vaccine had severe HA, abd. pain and nausea the next day. Called 800 line and received a call the next afternoon. Was told someone would call from co. to get the report on an adverse event, but no one did.
This case was reported by a consumer and described the occurrence of Guillain Barre syndrome in a female subject of unspecified age who was vaccinated with influenza virus vaccine (Influenza vaccine) for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Influenza vaccine. At an unspecified time after vaccination with Influenza vaccine, the subject experienced Guillain Barre syndrome. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the event was unspecified.
Flu like symptom; body aches; joint pains; headache; weakness; chills; feeling unwell; tiredness; anxiety; injection site pain and redness; injection site pain and redness; stiffness in legs and fingers; stiffness in legs and fingers; This is a spontaneous report from a contactable consumer (patient himself). A 70-years-old male patient who received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Formulation: Solution for injection, Batch/lot number: EN5318, Expiration date unknown), via an unspecified route of administration in left arm on 04Feb2021 at 15:30 at a single dose for COVID-19 immunization. Medical history included prostate cancer, autonomic nervous system imbalance, arthritis, drug hypersensitivity from an unspecified date and it was unknown if ongoing. The patient had allergies to medications, food, or other products included Keflex, Sulfa, Citalopram, Levofloxin, Nitrofurantoin Macrocrystalline, Alpha-D-Galactosidase, Famotidine, Metoprolol Tartrate, Doxycycline, and Morphine. Concomitant medications included lorazepam acetaminophen, diltiazem, aspirin (acetylsalicylic acid), simeticone (GAS-X) were taken for an unspecified indication. Neither the patient received any other vaccines within 4 weeks prior to the COVID vaccine nor tested for Covid-19. The patient was not diagnosed with covid-19 prior to vaccination. On 05Feb2021 at 12:00, the patient experienced flu like symptoms body aches, joint pains, headache, weakness, chills, feeling, tiredness, injection site pain and redness, stiffness in legs and fingers. The patient did not receive any treatment for these events. The outcome of events was not recovered.
Swelling at site of injection but only on one side; This is a spontaneous report from a contactable nurse. The reporter reported 2 reports for different patients. This is the second of 2 reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took Restylane Lyft in 2020. The patient experienced swelling at site of injection but only on one side on an unspecified date with outcome of recovered.  It resolved after about 7 days.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021751077 Same reporter/drug/AE, different patient
No symptoms noted at the 15 min waiting period . Returned to work; had something to eat; about 30 mins later, started feeling nauseated. Symptoms lasted about an hour.
During post vaccination observation period complaint of dizzy, warm, clammy and hypertensive BP 180/96. While being observed complaint of chest pain, transferred to ED. EKG and lab work within normal limits, Observed an additional hour with symptom relief and discharged to home.
Rash, UrticariaPruritus, SYMPTOMS FROM DAY2-12 AFTER INJECTION INCLUDING INJECTION SITE SORENESS, RASH, AXILLARY LYMPH NODE PAIN Narrative:  DAY 2-3: ARM SORENESS, INJECTION SITE RASH DAY 4: INJECTION SITE RASH DAY 7 AXILLARY NODE PAIN DAY 8: ITCHY RASH, INCREASED IN SIZE, AXILLARY PAIN DAY 9: ITCHY RASH, AXILLARY PAIN DAY 10: ITCHY RASH (LARGEST TODAY) AXILLARY PAIN DAY 11-12: AXILLARY PAIN  Other Relevant History:
he was very anxious, his anxiety level went through the roof; Tightness in his chest; He had pins and needles/He had pins and needles in his hair; it felt like he put charcoal on his skin a few times; he had to call in sick; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (he was very anxious, his anxiety level went through the roof), CHEST DISCOMFORT (Tightness in his chest), PARAESTHESIA (He had pins and needles/He had pins and needles in his hair), SENSORY DISTURBANCE (it felt like he put charcoal on his skin a few times) and ILLNESS (he had to call in sick) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 036A21A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jul-2021, the patient experienced ANXIETY (he was very anxious, his anxiety level went through the roof), CHEST DISCOMFORT (Tightness in his chest), PARAESTHESIA (He had pins and needles/He had pins and needles in his hair), SENSORY DISTURBANCE (it felt like he put charcoal on his skin a few times) and ILLNESS (he had to call in sick). At the time of the report, ANXIETY (he was very anxious, his anxiety level went through the roof), CHEST DISCOMFORT (Tightness in his chest), PARAESTHESIA (He had pins and needles/He had pins and needles in his hair), SENSORY DISTURBANCE (it felt like he put charcoal on his skin a few times) and ILLNESS (he had to call in sick) outcome was unknown.            Patient reported that he took multivitamins every third day.   This case was linked to MOD-2021-295014 (Patient Link).
SVT episode of 30 min with intermittent shorter episodes for 4 days. Previously asymptotic since cardiac ablation in 2017, ECG, echo and holter monitor  Diverticulitis, no previous occurrences, CBC, CMP, CT scan, IV antibiotics and oral antibiotics
About 5 minutes after my shot my throat started feeling warm and swollen. About 20 minutes later I had some tingling in my lips and tongue
received pneumococcal vaccine on 03-MAY-2006, 14-APR-2015 and 12-SEP-2017; This spontaneous report has been received from an other health professional referring to a 67 year old male patient. The patient's medical history, concurrent condition and concomitant medication were not reported.     On 03-MAY-2006 the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route, strength, batch/lot# and expiration date were unknown) for prophylaxis. On 14-APR-2015 the patient was vaccinated with pneumococcal 13v conj vaccine (crm197) (dose 0.5 ml; batch/lot# and expiration date were unknown) intramuscularly in the left deltoid. On 12-SEP-2017 the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose 0.5 ml) intramuscularly in the right deltoid for prophylaxis (inappropriate schedule of vaccine administration).  The case is linked to case# US-009507513-1811USA010091 due to the same patient.; Sender's Comments:  US-009507513-1811USA010091:
Patient refers to presenting "generalized rash" approximately 3 days after the administration of the vaccine, he refers to feeling itching all over his body. The patient refers to being taking OTC medications "BENADRYL" AND "ZYRTERC" without undergoing a medical evaluation.
Injection site swelling, redness, and discomfort, fatigue, muscle soreness, chills and feverish symptoms (no fever, temperature never over 98.6)
Chills; body aches; low grade fever; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK8730) via an unspecified route of administration in the left arm on 24Mar2021 at 02:45 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19. The patient did not have allergic to medications, food, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 10:00, patient experienced chills, body aches, low grade fever and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment received for the adverse events. The clinical outcome of the events chills, body aches, low grade fever and vomiting was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Soreness at injections site, fatigue, general achiness ,sweaty.  better Feb 2.
Developed B.L. knee pain 24 hours after imms/at 48 hours purpuric rash lower legs & abd pain - classic Hen. Sch. purpura evolved over next wk.  10/22/2009 hospital records received for 9/26-9/28/2009. ED visits 9/20 and 9/22/2009. Patient initially presented to ER with rash (legs, buttocks, scrotal area and penis), arthralgias, myalgias, bilateral knee swelling, dx'd with Henoch-Schonlein purpura.  Two days later, patient presents with new c/o's abdominal pain, nausea/vomiting. Stool guiac + for blood. TX: IV steroids,  IV fluids, IV Zofran,  NSAID for joint pain. PatientI returned on 9/24/2009 with more severe/persistant abdominl pain and was admitted for tests. R/O Intussusception. DC DX: Henoch-Schonlein purpura. ICD-9 codes 535.40, E9320, E9356, 287.0, 276.51
Within 4 hours after receiving first dose of vaccine , I experienced tiredness , fatigue, headache, body aches , fever,chills and was extremely thirsty. These symptoms lasted about 8 hours after the onset.
pt recv vax & awoke next day 13AUG98 w/chills, body aches, fever, sweats, swelling, hardness, redness @ inj site;also swelling rt axilla w/o redness;advised DPH, contact PMD;
took the shot and still had shingles/ Suspected Vaccination Failure; shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not applicable to this report. The reporter knows people (patients) that took the shingles shot and still had shingles. The follow up would not be possible as no contact details were available. This case was considered as suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
Child came in HD 9 days post second MMR administration with small pink pinpoint rash over upper and lower extremeties bilat and trunk of body. Grandmother states rash just occurred today  A-febrile. No other symptoms present.
patient felt heaviness in arm, and felt "far away" shortly after receiving the vaccine. She also felt warm and thirsty. She drank some water and then we took her blood pressure. she started to feel better and then felt a tighness in her neck. I retook her blood pressure and it was elevated. She then began having the chills, upon the last reading of blood pressure we call emergency services because it was elevated again. The last time we took her bp before emergency services came the reading was better. Ems checked her vitals and after a while let her decide whether or not she needed to go the hospital. She chose to leave and her son drove her home.
both sides of my face feel intermittently numb including lips. my right eye feels pressure and sometimes the vision is blurry. Same symptoms I had after having Covid 19 in May 2020
The day after vaccination the patient presented with a local red rash at the injection site. It was warm to the touch. He saw MD & MD was not concerned. He recommended TYLENOL.
Jaw hurts really bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw hurts really bad) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN JAW (Jaw hurts really bad). At the time of the report, PAIN IN JAW (Jaw hurts really bad) had resolved.            Concomitant product use included unspecified medications for heart pump. Treatment medication use was not provided by the reporter. Patient wife's reported that there was only a minor problem and no symptoms with the second shot.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Correspondence email attached. Outcome of the event added.
low grade fever and stomach cramps.; low grade fever and stomach cramps.; This is a spontaneous report from a Pfizer sponsored program. A contactable female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 31Mar2021 (Batch/Lot number unknown) as single dose for covid-19 immunization. The patients medical history and concomitant medications were not reported. It was reported that the reporter and his wife (the patient), both of them took the 1st dose last 31Mar2021 and scheduled for 2nd dose today (23Apr2021), which was more than 21 days. Both of them were experiencing low grade fever and stomach cramps. The reporter wanted to know if they need to take the 2nd dose today or not. The action taken in response to the event(s) for bnt162b2 was not applicable. The outcome of the events was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021470238 Different patient, same drug, same events;US-PFIZER INC-2021470238 Different patient, same drug, same event
+erythema and edema after vaccination that progressively worsened extending to below L. elbow.  Started receding after 4 days.  On 2/1/13, when I saw her in clinic, erythema and edema were mild over posterior lateral aspect of upper arm and above elbow.
Immediately upon receiving shot, significant pain occurred in left shoulder and arm. Pain is constant and is not going away.
Arm swelled on outside and turned red-Several hrs later inside arm from arm pit to elbow swelled and turned bright red lasted for 2 days-on third day began to subside and red faded